Resolution of invasive central nervous system aspergillosis in a transplant recipient
- PMID: 9244425
- DOI: 10.1038/sj.bmt.1700852
Resolution of invasive central nervous system aspergillosis in a transplant recipient
Abstract
Central nervous system (CNS) aspergillosis carries a uniformly poor prognosis in bone marrow transplant recipients. Amphotericin B can be bound to lipid carriers leading to improvement of its therapeutic index. We describe the successful medical management of CNS aspergillosis in an allogeneic bone marrow transplant patient with administration of Amphotericin B Lipid Complex.
Comment in
-
Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient.Bone Marrow Transplant. 1998 Aug;22(4):404-5. doi: 10.1038/sj.bmt.1701357. Bone Marrow Transplant. 1998. PMID: 9722081 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
